Clinically significant anxiety as a risk factor for Alzheimer's disease: Results from a 10‐year follow‐up community study
International Journal of Methods in Psychiatric Research · 2023-09 · 32 (3)
DOI: 10.1002/mpr.1934 ↗At a glance
Journal article in International Journal of Methods in Psychiatric Research, published online on 2023-01-03. Written by Patricia Gracia-García and 5 co-authors. Institution: Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain. Major MEDLINE topics: Alzheimer Disease. Cited 25 times so far (Crossref); 54 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Instituto de Salud Carlos III.
Topics: Demenz
Abstract (original language)
Objective
There is growing evidence for an association between anxiety and an increased risk of dementia, but it is not clear whether anxiety is a risk factor or a prodromic symptom. In this study, we investigated if clinically significant anxiety increases the risk of developing Alzheimer's disease (AD) up to 10 years later.
Methods
We used data from the longitudinal Zaragoza Dementia and Depression (ZARADEMP) Project. Excluding subjects with dementia at baseline left us with 3044 individuals aged >65 years. The Geriatric Mental State‐Automated Geriatric Examination for Computer Assisted Taxonomy (GMS‐AGECAT) package was used to identify cases and subcases of anxiety. AD was diagnosed by a panel of research psychiatrists according to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM‐IV) criteria. Multivariate survival analysis with a competing risk regression model was performed.
Results
We observed a significant association between clinically significant anxiety at baseline and AD risk within a 10‐year follow‐up (SHR 2.82 [95% CI 1.21–6.58]), after controlling for confounders including depression. In contrast, isolated symptoms of anxiety were not significantly associated with an increased incidence of AD.
Conclusion
Our results support the hypothesis that clinically significant anxiety is an independent risk factor for AD and not just a prodromic symptom. Future studies should clarify if treating anxiety reduces the incidence of AD.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain.
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Ministry of Science and Innovation, Madrid, Spain.
- Psychiatry Service, Hospital Universitario Miguel Servet, Zaragoza, Spain.
- Department of Medicine and Psychiatry, Universidad de Zaragoza, Zaragoza, Spain.
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales Medicine, Randwick, Australia.
- Psychiatry Service, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
ORCID profiles: Patricia Gracia-García, Juan Bueno-Notivol, Antonio Lobo
Funding
- Instituto de Salud Carlos III
Cite
APA
Gracia-García, P., Bueno-Notivol, J., Lipnicki, D. M., de la Cámara, C., Lobo, A., & Santabárbara, J. (2023). Clinically significant anxiety as a risk factor for Alzheimer's disease: Results from a 10‐year follow‐up community study. International Journal of Methods in Psychiatric Research, 32(3). https://doi.org/10.1002/mpr.1934
Vancouver
Gracia-García P, Bueno-Notivol J, Lipnicki DM, de la Cámara C, Lobo A, Santabárbara J. Clinically significant anxiety as a risk factor for Alzheimer's disease: Results from a 10‐year follow‐up community study. International Journal of Methods in Psychiatric Research. 2023;32(3). doi:10.1002/mpr.1934
BibTeX
@article{GraciaGarca2023,
author = {Gracia-García, Patricia and Bueno-Notivol, Juan and Lipnicki, Darren M and de la Cámara, Concepción and Lobo, Antonio and Santabárbara, Javier},
title = {Clinically significant anxiety as a risk factor for Alzheimer's disease: Results from a 10‐year follow‐up community study},
journal = {International Journal of Methods in Psychiatric Research},
year = {2023},
volume = {32},
number = {3},
doi = {10.1002/mpr.1934}
}
EUVIMED